Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing

European Journal of Mass Spectrometry

Volumn 14, Issue 3, 2008, Pages 163-170

  Thevis, Mario ^a   Lohmann, Wiebke ^b   Schrader, Yvonne ^a   Kohler, Maxie ^a   Bornatsch, Wolfgang ^c   Karst, Uwe ^b   Schänzer, Withelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c BAYER CROPSCIENCE AG   (Germany)

Author keywords

Doping; Mass spectrometry; Ostarine; SARM; Sport

Indexed keywords

ANABOLIC AGENT; ANDROGEN RECEPTOR; ANTIANDROGEN;

ARTICLE; DOPING; ELECTROCHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; SUBSTANCE ABUSE; SYNTHESIS;

ANABOLIC AGENTS; ANDROGEN ANTAGONISTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPING IN SPORTS; ELECTROCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION-REDUCTION; RECEPTORS, ANDROGEN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION;

EID: 50649113738     PISSN: 14690667     EISSN: None     Source Type: Journal    
DOI: 10.1255/ejms.924     Document Type: Article

References (35)

1. D.H. Catlin, B.D. Ahrens and Y. Kucherova, "Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine", Rapid Commun. Mass Spectrom. 16, 1273 (2002). doi: 10.1002/rcm.722
2. D.H. Catlin. M.H. Sekera, B.D. Ahrens, B. Starcevic, Y.-C. Chang and C.K. Hatton, "Tetrahydrogestrinone: discovery, synthesis, and detection in urine", Rapid Commun. Mass Spectrom. 18, 1245 (2004). doi: 10.1002/rcm.1495
3. M.H. Sekera, B.D. Ahrens, Y.C. Chang, B. Starcevic, C. Georgakopoulos and D.H. Catlin, "Another designer steroid: discovery, synthesis, and detection of 'madol' in urine", Rapid Commun. Mass Spectrom. 19, 781 (2005). doi: 10.1002/rcm.1858
4. A. Breidbach and D.H. Catlin, "RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry", Rapid Commun. Mass Spectrom. 15, 2379 (2001). doi: 10.1002/rcm.523
5. M. Thevis, O. Krug and W. Schänzer, "Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry", J. Mass Spectrom. 41, 332 (2006). doi: 10.1002/jms.993
6. M. Thevis, and W. Schänzer, "Emerging Drugs-Potential for misuse in sport and doping control detection strategies", Mini-Rev. Med. Chem. 7, 533 (2007). doi: 10.2174/138955707780619590
7. J.F. Levesque, E. Templeton, L. Trimble, C. Berthelette and N. Chauret, "Discovery, biosynthesis, and structure elucidation of metabolites of a doping agent and a direct analogue, tetrahydrogestrinone and gestrinone, using human hepatocytes", Anal. Chem. 77, 3164 (2005). doi: 10.1021/ac050150y
8. T. Kuuranne, A. Leinonen, W. Schänzer, M. Kamber, R. Kostiainen and M. Thevis, "Aryl-propionamide-derived selective androgen receptor modulators: LC-MS/MS characterization of the in vitro synthesized metabolites for doping control purposes", Drug Metab. Dispos. 36, 571 (2008). doi: 10.1124/dmd.107.017954
9. F. Botre, "Drugs of abuse and abuse of drugs in sportsmen: the role of in vitro models to study effects and mechanisms." Toxicol. In Vitro 17, 509 (2003). doi: 10.1016/ S0887-2333(03)00120-6
10. E. Levesque, M. Gaudreault, R. Houle and N. Chauret, "Evaluation of human hepatocyte incubation as a new tool for metabolism study of androstenedione and norandros-tenedione in a doping control perspective", J. Chromatogr. B 780, 145 (2002). doi: 10.1016/S1570-0232(02) 00444-0
11. W. Lohmann and U. Karst, "Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and limitations", Anal Bioanal Chem 391, 79 (2008). doi: 10.1007/s00216-007-1794-x
12. U. Karst, "Electrochemistry/mass spectrometry (EC/ MS)-a new tool to study drug metabolism and reaction mechanisms", Angew. Chem. Int. Ed. 43, 2476 (2004). doi: 10.1002/anie.200301763
13. H.P. Permentier, A.P. Bruins and R. Bischoff, "Electrochemistry-mass spectrometry in drug metabolism and protein research", Mini-Rev. Med. Chem. 8, 46 (2008). doi: 10.2174/138955708783331586
14. G. Hambitzer and J. Heitbaum, "Electrochemical thermospray mass spectrometry", Anal. Chem. 58, 1067 (1986). doi: 10.1021/ac00297a019
15. K.J. Volk, M.S. Lee, R.A. Yost and A. Brajter-Toth, " Electrochemistry/Thermospray/Tandem Mass Spectrometry in the Study of Biooxidation of Purines", Anal. Chem. 60, 720 (1988). doi: 10.1021/ac00158a025
16. F. Zhou and G.J. Van Berkel, "Electrochemistry combined on-line with electrospray mass spectrometry", Anal. Chem. 67, 3643 (1995). doi: 10.1021/ac00116a005
17. T.A. Getek, W.A. Korfmacher, T.A. McRae and J.A. Hinson, "Utility of solution electrochemistry mass spectrometry for investigating the formation and detection of biologically important conjugates of acetaminophen", J. Chromatogr. 245 (1989). doi: 10.1016/S0021-9673101)93919-6
18. S.M. van Leeuwen, B. Blankert, J.M. Kauffmann and U. Karst, "Prediction of clozapine metabolism by on-line electrochemistry/liquid chromatography/mass spectrometry", Anal. Bioanal. Chem. 382, 742 (2005). doi: 10.1007/s00216-005-3053-3
19. W. Lohmann and U. Karst, "Simulation of the detoxification of paracetamol using on-line electrochemistry/liquid chromatography/mass spectrometry", Anal. Bioanal. Chem. 386, 1701 (2006). doi: 10.1007/ s00216-006-0801-y
20. T. Johansson, L. Weidolf and U. Jurva, "Mimicry of phase I drug metabolism-novel methods for metabolite characterization and synthesis", Rapid Commun. Mass Spectrom. 21, 2323 (2007). doi: 10.1002/rcm.3077
21. U. Jurva, H.V. Wikstrom and A.P. Bruins, "In vitro mimicry of metabolic oxidation reactions by electrochemistry/mass spectrometry", Rapid Commun. Mass Spectrom. 14, 529 (2000). doi: 10.1002/(SICI)1097-0231(20000331)14:6<529::AID-RCM904>3.0.CO;2-H
22. U. Jurva, H.V. Wikstrom, L. Weidolf and A.P. Bruins, "Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions", Rapid Commun. Mass Spectrom. 17, 800 (2003). doi: 10.1002/rcm.978
23. K. Tahara, Y. Yano, K. Kanagawa, Y. Abe, J. Yamada, S. Iijima, M. Mochizuki and T. Nishikawa, "Successful preparation of metabolite of troglitazone by in-flow electrochemical reaction on coulometric electrode", Chem. Pharm. Bull. 55, 1207 (2007). doi: 10.1248/cpb.55.1207
24. U. Jurva, A. Holmen, G. Grönberg, C. Masimirembwa and L. Weidolf, "Electrochemical generation of electrophilic drug metabolites: characterization of amodiaquine quinoneimine and cysteinyl conjugates by MS, IR, and NMR", Chem. Res. Toxicol. 21, 928 (2008). doi: 10.1021/ tx700400c
25. K.G. Madsen, C. Skonberg, U. Jurva, C. Cornett, S.H. Hansen, T.H. Johansen and J. Olsen, "Bioactivation of diclofenac in vitro and in vivo: correlation to electrochemical studies", Chem. Res. Toxicol. 21, 1107 (2008). doi: 10.1021/tx700419d
26. World Anti-Doping Agency, "The 2008 Prohibited List", http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf, 28-11-2007
27. M. Thevis, M. Kamber and W. Schänzer, "Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes", Rapid Commun. Mass Spectrom. 20, 870 (2006). doi: 10.1002/rcm.2389
28. M. Thevis, M. Kohler, J. Maurer, N. Schlörer, M. Kamber and W. Schänzer, "Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis", Rapid Commun. Mass Spectrom. 21, 3477 (2007). doi: 10.1002/rcm.3247
29. M. Thevis, M. Kohler, A. Thomas, J. Maurer, N. Schlörer, M. Kamber and W. Schänzer, "Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS", Anal. Bioanal. Chem. 391, 251 (2008). doi: 10.1007/s00216-008-1882-6
30. W. Lohmann and U. Karst, "Generation and identification of reactive metabolites by electrochemistry and immobilized enzymes coupled on-line to liquid chromatography/mass spectrometry", Anal. Chem. 79, 6831 (2007). doi: 10.1021/ac071100r
31. C.A. Marhefka. W. Gao, K. Chung, J. Kim, Y. He, D. Yin, C. Bohl, J.T. Dalton and D.D. Miller, "Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators", J. Med. Chem. 47, 993 (2004). doi: 10.1021/jm030336u
32. H. Tucker and G.J. Chesterson, "Resolution of the non-steroidal antiandrogen 4′-cyano-3-[(4-fluorophenyl) sulfonyl]-2-hydroxy-2-methyl- 3′- (trifluoromethyl)-propionanilide and the determination of the absolute configuration of the active enantiomer", J. Med. Chem. 31, 885 (1988). doi: 10.1021/jm00399a034
33. H. Tucker, J.W. Crook and G.J. Chesterson, "Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides", J. Med. Chem. 31, 954 (1988). doi: 10.1021/jm00400a011
34. M. Thevis, G. Sigmund, A. Koch and W. Schänzer, "Determination of tuaminoheptane in doping control urine samples", Eur. J. Mass Spectrom. 13, 213 (2007). doi: 10.1255/ejms.875
35. M. Thevis and W. Schänzer, "Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins", J. Chromatogr. Sci. 43, 22 (2005).